Prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC)

Details

Files
Project Status:
Completed
Project Line:
Health Technology Review
Project Sub Line:
Technology Review
Project Number:
HC0060-000

Implementation Advice

Stakeholder Input Deadline June 8, 2023
Draft Report Posted  July 27, 2023
Stakeholder Feedback Deadline August 3, 2023
Final Report Posted August 30, 2023